Chugai Pharmaceutical Co., Ltd.

Chugai understands that patients and physicians may be interested in accessing investigational medicines prior to regulatory approval. At this time, however, Chugai does not offer expanded access to investigational medicines outside of our clinical trials. Chugai’s investigational medicines being developed in the U.S. are in the early stages of clinical development, therefore their potential risks and benefits to patients, as well as appropriate dosing, have not yet been sufficiently established.